Accelrys Receives Nasdaq Compliance Notice After Failure to File Financial Report | GenomeWeb

NEW YORK, Feb. 20 (GenomeWeb News) - Accelrys said on Friday that it has received a notice from the Nasdaq that the company is not in compliance with the exchange's rules after failing to file its fourth-quarter financial report on time.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.